Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS)

Overview of attention for article published in Frontiers in Neuroscience, November 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 13 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 77,622 followers.

RT @FrontNeurosci: New Research: Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombi…

01 Dec 2022

Reply Repost Favourite

New Research: Clinical safety and possible efficacy of tirofiban in combination with intravenous thrombolysis by recombinant tissue plasminogen activator for early treatment of capsular warning syndrome (CWS): The purpose of this study was… https://t.co/1n

28 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.